Stock Market News2 months Eli Lilly stock tumbles on Q3 miss, Zepbound sales fall short YouTube
X2 months Lilly’s Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks Zacks
X2 months Eli Lilly and Company (NYSE:LLY) Trading Down 6% After Earnings Miss MarketBeat
X2 months Eli Lilly and Company (NYSE:LLY) Updates FY 2024 Earnings Guidance MarketBeat
X2 months Eli Lilly’s weight-loss drug misses Wall Street expectations, shares tumble Investing.com
X2 months Eli Lilly (LLY) Lags Q3 Earnings and Revenue Estimates Zacks
X2 months Alphabet, Biogen, Humana rise premarket; AMD, Eli Lilly fall Investing.com
X2 months Eli Lilly stock crushed as weight loss sales, profits, disappoint Wall Street TheStreet
X2 months Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance Reddit
X2 months Eli Lilly Plummets On Rare — But ‘Big’ — Sales Miss For Diabetes, Weight-Loss Drugs Investor's Business Daily
X2 months Eli Lilly and Company (NYSE:LLY) Stake Raised by Smith Group Asset Management LLC MarketBeat
X2 months Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again? Zacks
X2 months Eli Lilly and Company (NYSE:LLY) Shares Up 0.9% After Dividend Announcement MarketBeat
X2 months Semanteon Capital Management LP Makes New Investment in Eli Lilly and Company (NYSE:LLY) MarketBeat
X2 months Eli Lilly and Company (NYSE:LLY) Declares $1.30 Quarterly Dividend MarketBeat
X2 months Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? Zacks
X2 months Eli Lilly and Company (NYSE:LLY) Shares Up 0.1% on Analyst Upgrade MarketBeat
X2 months Eli Lilly gets nod to launch weight-loss drug in Hong Kong – Bloomberg News Investing.com
X2 months Dakota Wealth Management Sells 833 Shares of Eli Lilly and Company (NYSE:LLY) MarketBeat
X2 months NVS vs. LLY: Which Stock Is the Better Value Option? Zacks
X2 months Eli Lilly Is Putting On Some Weight As Earnings Near Seeking Alpha
X2 months Eli Lilly and Company (NYSE:LLY) Trading Down 1% – What’s Next? MarketBeat
X2 months Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly’s Obesity Triplet Investor's Business Daily
X2 months Competition will make weight-loss drugs better, cheaper and bigger The Economist
X2 months Lightning Round: Wait for a pullback in Eli Lilly to buy, says Jim Cramer YouTube
X2 months Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release Zacks
X2 months Eli Lilly and Company (LLY) to Release Quarterly Earnings on Wednesday MarketBeat
X2 months Sequoia Financial Advisors LLC Increases Stake in Eli Lilly and Company (NYSE:LLY) MarketBeat
X2 months Eli Lilly and Company (NYSE:LLY) Trading Up 0.2% – Still a Buy? MarketBeat
X2 months Can Roche Challenge Lilly and Novo in the Weight Loss Market? MarketBeat
X2 months Plimoth Trust Co. LLC Has $4.63 Million Stock Position in Eli Lilly and Company (NYSE:LLY) MarketBeat
X2 months Eli Lilly and Company (NYSE:LLY) Trading Down 0.6% – Here’s What Happened MarketBeat
X2 months 2,265 Shares in Eli Lilly and Company (NYSE:LLY) Bought by Penn Davis Mcfarland Inc. MarketBeat
X2 months Eli Lilly Buy On Weakness Signal (Technical Analysis) Seeking Alpha
X2 months Eli Lilly and Company (NYSE:LLY) Shares Purchased by First Citizens Bank & Trust Co. MarketBeat
X8 months Can biotech startups upstage Eli Lilly and Novo Nordisk? The Economist
X10 months The battle over the trillion-dollar weight-loss bonanza The Economist
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.